The Centers for Medicare & Medicaid Services (CMS) has finalized its outpatient prospective payment system (OPPS) and physician fee schedule rules for calendar year 2022. In the final OPPS rule, as proposed, CMS continued controversial reimbursement cuts of 30% for drugs acquired through the 340B program and adopted significantly higher penalties for non-compliance with standard charge public reporting requirements.